Improvement of insulin resistance and early atherosclerosis in patients after gastric banding (Q42457564)

31 October 2017

Improvement of insulin resistance and early atherosclerosis in patients after gastric banding (English)

1 reference

31 October 2017

1 reference

1 reference

Ursula Hanusch-Enserer

1

1 reference

31 October 2017

Edmund Cauza

2

1 reference

31 October 2017

Marita Spak

3

1 reference

31 October 2017

Georg Endler

4

1 reference

31 October 2017

Attila Dunky

5

1 reference

31 October 2017

Andrea Tura

6

1 reference

31 October 2017

Oswald Wagner

7

1 reference

31 October 2017

Harald R Rosen

8

1 reference

31 October 2017

Giovanni Pacini

9

1 reference

31 October 2017

Rudolf Prager

10

1 reference

31 October 2017

1 February 2004

1 reference

31 October 2017

1 reference

31 October 2017

12

1 reference

31 October 2017

2

1 reference

31 October 2017

284-291

1 reference

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

31 October 2017

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.36

The disease burden associated with overweight and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.36

Variability of body weight and health outcomes in the Framingham population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.36

Insulin-resistant prediabetic subjects have more atherogenic risk factors than insulin-sensitive prediabetic subjects: implications for preventing coronary heart disease during the prediabetic state.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.36

Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.36

Insulin resistance implications for type II diabetes mellitus and coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.36

Inflammatory pathways in atherosclerosis and acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.36

C-reactive protein and coronary artery disease: influence of obesity, caloric restriction and weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.36

Endothelial-leukocyte adhesion molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.36

Soluble adhesion molecules and unstable coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.36

A major role for VCAM-1, but not ICAM-1, in early atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.36

Laparoscopic adjustable gastric banding: a prospective 4-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.36

Health outcomes of severely obese type 2 diabetic subjects 1 year after laparoscopic adjustable gastric banding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.36

Laparoscopic adjustable gastric banding in the treatment of morbid obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.36

Blood pressure and pulse pressure during long-term weight loss in the obese: the Swedish Obese Subjects (SOS) Intervention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.36

Persistent elevation and metabolic dependence of circulating E-selectin after delivery in women with gestational diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.36

A model-based method for assessing insulin sensitivity from the oral glucose tolerance test

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.36

Increased plasma leptin in gestational diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.36

Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.36

High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.36

Minor long-term changes in weight have beneficial effects on insulin sensitivity and beta-cell function in obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.36

Improvement of glycemic control by 1 year of insulin therapy leads to a sustained decrease in sE-selectin concentrations in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.36

Early upregulation of endothelial adhesion molecules in obese hypertensive men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.36

Weight reduction decreases soluble cellular adhesion molecules in obese women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.36

Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.36

A prospective study of obesity and risk of coronary heart disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.36

Insulin resistance and cardiovascular disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.36

High serum concentrations of soluble E-selectin in patients with impaired glucose tolerance with hyperinsulinemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.36

Improvements in insulin sensitivity and beta-cell function (HOMA) with weight loss in the severely obese. Homeostatic model assessment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.36

Circulating vascular cell adhesion molecule-1 (VCAM-1) in atherosclerotic NIDDM patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.36

Weight loss and endothelial function in obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2004.36

31 March 2020

Identifiers

DOI

10.1038/OBY.2004.36

1 reference

31 October 2017

1 reference